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Introduction
Different reports of shared manifestations for malignancy
and rheumatic diseases in children since 1970s indicate
the presentation of malignancies, particularly ALL, with
musculoskeletal (MS) symptoms.
Objectives
To evaluate the rate and the characteristics of hemato-
logical malignancies in Iranian children with joint man-
ifestations based on two different scopes of data
collection since 1981.
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Methods
In this retrospective review, we considered two different
aspects of evaluation within two pediatric tertiary
centers in Iran: 1- Children’s Hematology/Oncology
Research Center, 2- Pediatric Rheumatology Center.
Results
Here we report the results of 3 studies (I, II & III) con-
ducted through 1981-2006, followed by current (IV)
study performed since 2006. Findings of four different
studies are mentioned in detail, in Table 1. An additional
study was performed in parallel to study I comprising 46
dead patients in addition to 54 current patients, which
showed the similar results. ALL was the most frequent
type of malignancy (80-100%).
Conclusion
The relative increase in the rate of malignancy in this
review (period of 1981-2012) could be an alarm to per-
form BM aspiration in children with joint manifestations
harboring the following as “Red Flags": (i) Boys at the age
of 5-7, (ii) Large joint involvement (particularly hip, knee
and ankle) and (iii) Arthralgia at presentation. According
to recent recommendations by ACR for early aggressive
treatments in JIA patients, this precautionary measure
may minimize the potential dangers and consequences of
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